Semaglutide Safety
4 articles on Semaglutide Safety, written by Shotlee and medically reviewed for clinical accuracy.
Wegovy Linked to Sudden Vision Loss Risk, Study Finds
Researchers analyzing over 30 million FDA safety reports found Wegovy associated with nearly five times higher odds of ischemic optic neuropathy (ION), or 'eye stroke,' compared to Ozempic. This sudden vision loss risk was strongest in men on Wegovy. While rare, these findings urge caution and further study for GLP-1 users.
5 min read
Telangana DCA Warns Against Unsupervised Semaglutide Use Amid Weight Loss Demand
The Telangana Drugs Control Administration (DCA) has issued a strong warning against unsupervised use of semaglutide, a popular GLP-1 drug for weight loss and Type-2 diabetes management. With generics now available from Sun Pharma, Dr. Reddy's, Zydus, and Glenmark following patent expiry, demand is surging—but so are risks like acute pancreatitis and kidney injury. Always consult a doctor for proper assessment and prescription.
5 min read
Hair Loss, Bloating, Regret: Dangers of DIY Ozempic Jabs
Elfina lost 3kg in two weeks on DIY Ozempic but faced clumps of hair falling out, leading to regret. Nafisa stopped after one jab due to painful bloating. This exclusive look reveals the perils of bypassing medical supervision for Semaglutide.
5 min read
Ozempic Recall: Understanding the Risks & Staying Informed About Semaglutide
A recent recall of Ozempic in Canada highlights the importance of staying informed about your medications. This post explains the recall, its potential implications, and how to stay safe while navigating your health journey.
3 min read